世界の多発性硬化症薬物治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Sclerosis Drugs Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4534
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、多発性硬化症薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターフェロン、免疫調節剤、免疫抑制剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・多発性硬化症薬物治療の市場動向
・企業の競争状況、市場シェア
・多発性硬化症薬物治療の種類別市場規模と予測2016-2027（インターフェロン、免疫調節剤、免疫抑制剤）
・多発性硬化症薬物治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局、その他）
・多発性硬化症薬物治療の北米市場規模2016-2027（アメリカ、カナダ）
・多発性硬化症薬物治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性硬化症薬物治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性硬化症薬物治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性硬化症薬物治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Roche、Biogen、Teva Pharmaceutical、Merck、Novartis、Bayer、Sanofi、Acorda Therapeutics、Questcor Pharmaceuticals、AbbVie、Opexa Therapeutics、Genzyme Corporation）
・結論

Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of the course of disease as the characteristics, multiple sclerosis drug treatment can reduce the recurrence rate of this disease and slow down the process of disability.

Market Analysis and Insights: Global Multiple Sclerosis Drugs Treatment Market
The global Multiple Sclerosis Drugs Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Sclerosis Drugs Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Sclerosis Drugs Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Sclerosis Drugs Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Sclerosis Drugs Treatment market.

Global Multiple Sclerosis Drugs Treatment Scope and Market Size
Multiple Sclerosis Drugs Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Drugs Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Interferon
Immunomodulator
Immunosuppressant

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Biogen
Teva Pharmaceutical
Merck
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
AbbVie
Opexa Therapeutics
Genzyme Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Interferon
1.2.3 Immunomodulator
1.2.4 Immunosuppressant
1.3 Market by Application
1.3.1 Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Sclerosis Drugs Treatment Market Perspective (2016-2027)
2.2 Multiple Sclerosis Drugs Treatment Growth Trends by Regions
2.2.1 Multiple Sclerosis Drugs Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Sclerosis Drugs Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Sclerosis Drugs Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Sclerosis Drugs Treatment Industry Dynamic
2.3.1 Multiple Sclerosis Drugs Treatment Market Trends
2.3.2 Multiple Sclerosis Drugs Treatment Market Drivers
2.3.3 Multiple Sclerosis Drugs Treatment Market Challenges
2.3.4 Multiple Sclerosis Drugs Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue
3.1.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue (2016-2021)
3.1.2 Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Sclerosis Drugs Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Sclerosis Drugs Treatment Revenue
3.4 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Drugs Treatment Revenue in 2020
3.5 Multiple Sclerosis Drugs Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
3.7 Date of Enter into Multiple Sclerosis Drugs Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Sclerosis Drugs Treatment Breakdown Data by Type
4.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2016-2021)
4.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2022-2027)

5 Multiple Sclerosis Drugs Treatment Breakdown Data by Application
5.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Application (2016-2021)
5.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Sclerosis Drugs Treatment Market Size (2016-2027)
6.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type
6.2.1 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021)
6.2.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027)
6.2.3 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2027)
6.3 North America Multiple Sclerosis Drugs Treatment Market Size by Application
6.3.1 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021)
6.3.2 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027)
6.3.3 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2027)
6.4 North America Multiple Sclerosis Drugs Treatment Market Size by Country
6.4.1 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021)
6.4.2 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Multiple Sclerosis Drugs Treatment Market Size (2016-2027)
7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type
7.2.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021)
7.2.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027)
7.2.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2027)
7.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Application
7.3.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021)
7.3.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027)
7.3.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2027)
7.4 Europe Multiple Sclerosis Drugs Treatment Market Size by Country
7.4.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021)
7.4.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size (2016-2027)
8.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type
8.2.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application
8.3.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region
8.4.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Sclerosis Drugs Treatment Market Size (2016-2027)
9.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type
9.2.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2027)
9.3 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application
9.3.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2027)
9.4 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country
9.4.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size (2016-2027)
10.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type
10.2.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application
10.3.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country
10.4.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Multiple Sclerosis Drugs Treatment Introduction
11.1.4 Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Multiple Sclerosis Drugs Treatment Introduction
11.2.4 Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Multiple Sclerosis Drugs Treatment Introduction
11.3.4 Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.3.5 Biogen Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Multiple Sclerosis Drugs Treatment Introduction
11.5.4 Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Multiple Sclerosis Drugs Treatment Introduction
11.6.4 Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Multiple Sclerosis Drugs Treatment Introduction
11.7.4 Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Multiple Sclerosis Drugs Treatment Introduction
11.8.4 Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Acorda Therapeutics
11.9.1 Acorda Therapeutics Company Details
11.9.2 Acorda Therapeutics Business Overview
11.9.3 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Introduction
11.9.4 Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.9.5 Acorda Therapeutics Recent Development
11.10 Questcor Pharmaceuticals
11.10.1 Questcor Pharmaceuticals Company Details
11.10.2 Questcor Pharmaceuticals Business Overview
11.10.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Introduction
11.10.4 Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.10.5 Questcor Pharmaceuticals Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Multiple Sclerosis Drugs Treatment Introduction
11.11.4 AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.11.5 AbbVie Recent Development
11.12 Opexa Therapeutics
11.12.1 Opexa Therapeutics Company Details
11.12.2 Opexa Therapeutics Business Overview
11.12.3 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Introduction
11.12.4 Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.12.5 Opexa Therapeutics Recent Development
11.13 Genzyme Corporation
11.13.1 Genzyme Corporation Company Details
11.13.2 Genzyme Corporation Business Overview
11.13.3 Genzyme Corporation Multiple Sclerosis Drugs Treatment Introduction
11.13.4 Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021)
11.13.5 Genzyme Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Interferon
Table 3. Key Players of Immunomodulator
Table 4. Key Players of Immunosuppressant
Table 5. Global Multiple Sclerosis Drugs Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Multiple Sclerosis Drugs Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Multiple Sclerosis Drugs Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Multiple Sclerosis Drugs Treatment Market Share by Regions (2016-2021)
Table 9. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Multiple Sclerosis Drugs Treatment Market Share by Regions (2022-2027)
Table 11. Multiple Sclerosis Drugs Treatment Market Trends
Table 12. Multiple Sclerosis Drugs Treatment Market Drivers
Table 13. Multiple Sclerosis Drugs Treatment Market Challenges
Table 14. Multiple Sclerosis Drugs Treatment Market Restraints
Table 15. Global Multiple Sclerosis Drugs Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Multiple Sclerosis Drugs Treatment Market Share by Players (2016-2021)
Table 17. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2020)
Table 18. Ranking of Global Top Multiple Sclerosis Drugs Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Multiple Sclerosis Drugs Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
Table 22. Date of Enter into Multiple Sclerosis Drugs Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Multiple Sclerosis Drugs Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Multiple Sclerosis Drugs Treatment Product
Table 65. Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Multiple Sclerosis Drugs Treatment Product
Table 70. Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Biogen Company Details
Table 73. Biogen Business Overview
Table 74. Biogen Multiple Sclerosis Drugs Treatment Product
Table 75. Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 76. Biogen Recent Development
Table 77. Teva Pharmaceutical Company Details
Table 78. Teva Pharmaceutical Business Overview
Table 79. Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Product
Table 80. Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Multiple Sclerosis Drugs Treatment Product
Table 85. Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Multiple Sclerosis Drugs Treatment Product
Table 90. Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Multiple Sclerosis Drugs Treatment Product
Table 95. Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 96. Bayer Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 100. Sanofi Recent Development
Table 101. Acorda Therapeutics Company Details
Table 102. Acorda Therapeutics Business Overview
Table 103. Acorda Therapeutics Multiple Sclerosis Drugs Treatment Product
Table 104. Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 105. Acorda Therapeutics Recent Development
Table 106. Questcor Pharmaceuticals Company Details
Table 107. Questcor Pharmaceuticals Business Overview
Table 108. Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Product
Table 109. Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 110. Questcor Pharmaceuticals Recent Development
Table 111. AbbVie Company Details
Table 112. AbbVie Business Overview
Table 113. AbbVie Multiple Sclerosis Drugs Treatment Product
Table 114. AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 115. AbbVie Recent Development
Table 116. Opexa Therapeutics Company Details
Table 117. Opexa Therapeutics Business Overview
Table 118. Opexa Therapeutics Multiple Sclerosis Drugs Treatment Product
Table 119. Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 120. Opexa Therapeutics Recent Development
Table 121. Genzyme Corporation Company Details
Table 122. Genzyme Corporation Business Overview
Table 123. Genzyme Corporation Multiple Sclerosis Drugs Treatment Product
Table 124. Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2016-2021) & (US$ Million)
Table 125. Genzyme Corporation Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Drugs Treatment Market Share by Type: 2020 VS 2027
Figure 2. Interferon Features
Figure 3. Immunomodulator Features
Figure 4. Immunosuppressant Features
Figure 5. Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Multiple Sclerosis Drugs Treatment Report Years Considered
Figure 11. Global Multiple Sclerosis Drugs Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Multiple Sclerosis Drugs Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Multiple Sclerosis Drugs Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Multiple Sclerosis Drugs Treatment Market Share by Regions (2022-2027)
Figure 15. Global Multiple Sclerosis Drugs Treatment Market Share by Players in 2020
Figure 16. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Multiple Sclerosis Drugs Treatment Revenue in 2020
Figure 18. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Multiple Sclerosis Drugs Treatment Market Share by Type (2016-2027)
Figure 22. North America Multiple Sclerosis Drugs Treatment Market Share by Application (2016-2027)
Figure 23. North America Multiple Sclerosis Drugs Treatment Market Share by Country (2016-2027)
Figure 24. United States Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Multiple Sclerosis Drugs Treatment Market Share by Type (2016-2027)
Figure 28. Europe Multiple Sclerosis Drugs Treatment Market Share by Application (2016-2027)
Figure 29. Europe Multiple Sclerosis Drugs Treatment Market Share by Country (2016-2027)
Figure 30. Germany Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Region (2016-2027)
Figure 40. China Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Multiple Sclerosis Drugs Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Multiple Sclerosis Drugs Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Multiple Sclerosis Drugs Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 67. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 68. Questcor Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 69. AbbVie Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 70. Opexa Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 71. Genzyme Corporation Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

多発性硬化症（MS）治療薬のグローバル市場調査 2019年

Global Multiple Sclerosis (MS) Drugs Market Professional Survey Report 2019
QYR9NV08707 2019年11月14日 111Pages
※本調査レポートは、多発性硬化症（MS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキ...

世界の筋萎縮性側索硬化症治療薬市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3797 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、筋萎縮性側索硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、エダラボン（ラディカバ）、その他）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4533 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5025 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模...

世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年）

Global Sinusitis Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6007 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、副鼻腔炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、NSAIDS、充血除去剤・粘液溶解剤、鼻洗浄キット）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界の遅発性ジスキネジア(TD)治療薬市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6032 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遅発性ジスキネジア(TD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、デュテトラベナジン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の勃起不全治療薬市場規模・現状・予測（2021年-2027年）

Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5727 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、勃起不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetes Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5701 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、GLP-1、インスリン）、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の尿失禁治療薬市場規模・現状・予測（2021年-2027年）

Global Urinary Incontinence Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6059 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、尿失禁治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痙薬、筋弛緩薬、α遮断薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

多発性硬化症（MS）治療薬のグローバル市場調査 2019年 The global Multiple Sclerosis (MS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Multiple Sclerosis (MS) Drugs volume and value at global level, regional level and company level. From a glob…
世界の小売薬局市場規模・現状・予測（2021年-2027年） A retail pharmacy refers to a retail store of medicines. Market Analysis and Insights: Global Retail Pharmacy Market The global Retail Pharmacy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in…
二次性進行性多発性硬化症薬のグローバル市場調査 2019年 The global Secondary Progressive Multiple Sclerosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Secondary Progressive Multiple Sclerosis Drug volume and value at global level, regional leve…
二次性進行性多発性硬化症薬のグローバル市場調査 2019年 The global Secondary Progressive Multiple Sclerosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Secondary Progressive Multiple Sclerosis Drug volume and value at global level, regional leve…
世界のペット専用医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pet Speciality Drugs Market The global Pet Speciality Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…